Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer

Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015

Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?

Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
27 Feb 2015

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer

Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015

New approach to prostate cancer screening

Dr Sanoj Punnen - University of Miami, Miami, USA
New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )
27 Feb 2015

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Prof Thomas Powles - Barts Health, London, UK
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer ( Prof Thomas Powles - Barts Health, London, UK )
26 Feb 2015

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015

mRCC: Are we doing all we can to manage adverse events?

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Understanding the patient's perspective

Dr David Cella - Northwestern University, Chicago, USA
mRCC: Understanding the patient's perspective ( Dr David Cella - Northwestern University, Chicago, USA )
11 Feb 2015

mRCC: Panel discussion

Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella
mRCC: Panel discussion ( Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella )
11 Feb 2015

mRCC: Closing remarks

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Closing remarks ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

ecancermedicalscience Special Issue: Fertility sparing

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Special Issue: Fertility sparing ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
4 Feb 2015